Role of cAMP in modulating relaxation kinetics and the force-frequency relation in mitral regurgitation heart failure

L A Mulieri1, B J Leavitt, R K Wright

  • 1Dept. Molec. Physiol. & Biophys, University of Vermont, Burlington 05405, USA.

Insights

Heart diseases impair the force-frequency relation (FFR) due to altered excitation-contraction coupling. Restoring calcium pump activity with forskolin improved FFR and relaxation in failing hearts, suggesting a key mechanism.

Area of Science:

  • Cardiology
  • Cardiac Physiology
  • Molecular Cardiology

Background:

  • The force-frequency relation (FFR) describes how heart muscle contraction force changes with stimulation frequency.
  • Alterations in FFR are associated with various heart diseases, including heart failure and coronary artery disease.
  • The excitation-contraction coupling system plays a critical role in regulating cardiac contractility and FFR.

Purpose of the Study:

  • To investigate the association between heart diseases and alterations in the force-frequency relation (FFR).
  • To examine the role of altered excitation-contraction coupling in blunting the FFR.
  • To explore the involvement of the calcium pump mechanism in FFR changes in heart disease.

Main Methods:

  • Measured and compared FFR in isolated myocardium from non-failing and failing hearts with various conditions.
  • Analyzed isometric twitch relaxation kinetics in response to stimulation frequency and forskolin.
  • Developed a mathematical model to simulate isometric twitch relaxation based on calcium pump kinetics.

Main Results:

  • A linear relationship was found between optimum stimulation frequency and the % slope of FFR across all disease types.
  • Altered control of the calcium pump, specifically depressed protein kinase-A activity, was implicated in prolonged relaxation and depressed FFR in mitral regurgitation.
  • Forskolin treatment restored FFR and relaxation kinetics in failing myocardium to non-failing levels.

Conclusions:

  • Altered calcium pump activity is a key mechanism underlying depressed FFR and impaired relaxation in heart disease.
  • The findings support a model where reduced protein kinase-A activity impacts calcium pump function in conditions like mitral regurgitation.
  • Targeting the calcium pump may offer therapeutic strategies for heart diseases characterized by impaired FFR.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...